Mometasone Furoate

   
Google
 
Web NewDrugInformation.com

Mometasone Furoate


Drug - Mometasone Furoate
The trade name of the product as shown on the labeling.

Dosage - OINTMENT; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Mometasone Furoate
Multiple ingredients are in alphabetical order.

Strength - 0.1%
The potency of the active ingredient(s), Mometasone Furoate. May repeat for multiple part products.

Applicant - QLT USA
The firm name holding legal responsibility for Mometasone Furoate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076481
The FDA assigned number to Mometasone Furoate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Mometasone Furoate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 14, 2003
The date Mometasone Furoate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Mometasone Furoate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Mometasone Furoate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Qlt Usa Inc
The full name of the firm holding legal responsibility for the new application of Mometasone Furoate.

Mometasone Furoate